multiple sclerosis

Novartis confirms positive benefit-risk profile of Gilenya following CHMP review
The Fly on the Wall
Fri, 04/20/12 - 10:38 am
CHMP
Novartis
MS
multiple sclerosis
Biogen's Fampyra Launched in Canada
Yahoo/Zacks
Sat, 04/14/12 - 12:39 pm
Biogen Idec
Fampyra
multiple sclerosis
Questcor Could Shoot Higher On Acthar's Versatility
Motley Fool
Sat, 04/14/12 - 12:23 pm
Questcor
Acthar
multiple sclerosis
nephrotic syndrome
infantile spasms
Novartis MS Patient Develops Rare Brain Disease
Pharmalot
Fri, 04/13/12 - 09:57 am
Gilenya
MS
multiple sclerosis
PML
Novartis
Watchdog says FDA should consider restricting Gilenya
Fierce Pharma
Fri, 04/6/12 - 11:50 am
FDA
Gilenya
Novartis
multiple sclerosis
MS
Coronado Biosciences: Provides Investors With 2 Distinct Pipelines And Significant Market Potential
Seeking Alpha
Sun, 04/1/12 - 12:18 pm
Coronado Biosciences
Crohn's Disease
ulcerative colitis
multiple sclerosis
OvaMed
CNDO-109
acute myeloid leukemia
Teva reports favorable Laquinimod trial results
Globes, Israel
Sun, 03/18/12 - 11:30 am
Teva Pharmaceuticals
laquinimod
multiple sclerosis
BrainStorm Cell initiates study for MS
The Fly on the Wall
Mon, 03/12/12 - 05:28 pm
MS
multiple sclerosis
BrainStorm Cell Therapeutics
stem cells
Sanofi faces uphill struggle in MS drug market
Reuters, UK
Mon, 02/6/12 - 11:50 am
MS
multiple sclerosis
Sanofi
Novartis
Biogen Idec: The Patriots of Biotechs
PharmExec
Thu, 02/2/12 - 11:06 am
Biogen Idec
Tysabri
Elan
biotech
BG-12
MS
multiple sclerosis
[video] Cramer: Biogen Idec's Profit Pipeline
CNBC
Fri, 01/27/12 - 10:17 am
Biogen Idec
multiple sclerosis
Tysabri label change could add $1B to sales
Fierce Pharma
Mon, 01/23/12 - 12:00 pm
Tysabri
MS
multiple sclerosis
Biogen Idec
Teva Rises to Eight-Month High on Novartis News
BusinessWeek
Sun, 01/22/12 - 12:28 pm
Teva Pharmaceuticals
Gilenya
Novartis
Copaxone
multiple sclerosis
Novartis drug investigated after 11 deaths
Yahoo/AP
Sat, 01/21/12 - 01:15 pm
Novartis
Gilenya
multiple sclerosis
Biogen, Elan Win U.S. FDA Approval of Tysabri Label Change to Target Use
Bloomberg
Sat, 01/21/12 - 01:04 pm
Biogen Idec
Elan
Tysabri
multiple sclerosis
Novartis falls 4% on MS drug concerns
Marketwatch
Fri, 01/20/12 - 12:19 pm
MS
Novartis
Gilenya
multiple sclerosis
Novartis’s Gilenya Reviewed After 11 Deaths
Bloomberg
Fri, 01/20/12 - 10:06 am
Novartis
Gilenya
MS
multiple sclerosis
EMA
Questcor: A Mid Cap Bio-Pharma With Bullish Indicators
Seeking Alpha
Tue, 01/17/12 - 10:26 am
Questcor
lupus
nephrotic syndrome
infantile spasms
MS
multiple sclerosis
H.P. Acthar Gel
Sanofi Says MS Pill Aubagio Fails to Beat Rebif in Trial
Bloomberg
Tue, 12/20/11 - 10:23 am
Sanofi
MS
Aubagio
Rebif
multiple sclerosis
Merck KGaA
Gilenya trial could ease safety worries
Baltimore Sun, MD
Thu, 12/15/11 - 11:35 am
MS
multiple sclerosis
Gilenya
Novartis

Pages